Catherine Bird

1.4k total citations
9 papers, 225 citations indexed

About

Catherine Bird is a scholar working on Clinical Psychology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Catherine Bird has authored 9 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Psychology, 5 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Catherine Bird's work include Psychedelics and Drug Studies (6 papers), Chemical synthesis and alkaloids (5 papers) and Cannabis and Cannabinoid Research (3 papers). Catherine Bird is often cited by papers focused on Psychedelics and Drug Studies (6 papers), Chemical synthesis and alkaloids (5 papers) and Cannabis and Cannabinoid Research (3 papers). Catherine Bird collaborates with scholars based in United Kingdom, United States and Finland. Catherine Bird's co-authors include James Rucker, Tom Minichillo, Allan H. Young, Curtis W. Marean, Simon Ruffell, Mário F. Juruena, Ekaterina Malievskaia, Gemma Knight, Sam Williams and Hans Eriksson and has published in prestigious journals such as Journal of Affective Disorders, BMJ Open and Journal of Archaeological Science.

In The Last Decade

Catherine Bird

9 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Bird United Kingdom	7	155	98	63	42	32	9	225
Carl A. P. Ruck United States	7	231 1.5×	88 0.9×	51 0.8×	31 0.7×	21 0.7×	16	328
Athanasios Markopoulos Greece	6	147 0.9×	75 0.8×	107 1.7×	16 0.4×	26 0.8×	20	223
Nicolas Langlitz United States	9	143 0.9×	57 0.6×	27 0.4×	97 2.3×	25 0.8×	48	350
Constantino Manuel Torres United States	8	92 0.6×	19 0.2×	11 0.2×	7 0.2×	53 1.7×	12	283
Petter Grahl Johnstad Norway	9	238 1.5×	117 1.2×	75 1.2×	40 1.0×	5 0.2×	21	293
Timothy I. Michaels United States	9	374 2.4×	185 1.9×	112 1.8×	59 1.4×	6 0.2×	16	441
David Dupuis France	9	240 1.5×	120 1.2×	73 1.2×	24 0.6×	18 0.6×	20	284
Natalie Rodriguez United States	4	160 1.0×	90 0.9×	62 1.0×	20 0.5×	3 0.1×	7	256
Taylor Lyons United Kingdom	7	272 1.8×	145 1.5×	124 2.0×	25 0.6×	3 0.1×	13	331
Ekaterina Malievskaia United States	6	317 2.0×	243 2.5×	128 2.0×	20 0.5×	4 0.1×	8	331

Countries citing papers authored by Catherine Bird

Since Specialization

Citations

This map shows the geographic impact of Catherine Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Bird more than expected).

Fields of papers citing papers by Catherine Bird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Bird. The network helps show where Catherine Bird may publish in the future.

Co-authorship network of co-authors of Catherine Bird

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Bird. A scholar is included among the top collaborators of Catherine Bird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Bird. Catherine Bird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Rucker, James, Matthew Butler, Catherine Bird, et al.. (2024). Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study. Headache The Journal of Head and Face Pain. 64(10). 1309–1317. 3 indexed citations

Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2022). The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls. Journal of Psychopharmacology. 36(12). 1350–1361. 24 indexed citations

Rucker, James, Lindsey Marwood, Catherine Bird, et al.. (2022). The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Journal of Psychopharmacology. 36(1). 114–125. 54 indexed citations

Rucker, James, Hassan Jafari, Tim Mantingh, et al.. (2021). Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. BMJ Open. 11(12). e056091–e056091. 13 indexed citations

Yalın, Nefize, et al.. (2021). Clinical characteristics and impacts of HIV infection in people with bipolar disorders. Journal of Affective Disorders. 294. 794–801. 2 indexed citations

Bird, Catherine, et al.. (2021). Psilocybin and MDMA for the treatment of trauma-related psychopathology. International Review of Psychiatry. 33(3). 229–249. 42 indexed citations

Bird, Catherine, Luke A. Jelen, Gemma Knight, et al.. (2020). Historic psychedelic drug trials and the treatment of anxiety disorders. Depression and Anxiety. 37(12). 1261–1279. 24 indexed citations

Ruffell, Simon, et al.. (2020). The pharmacological interaction of compounds in ayahuasca: a systematic review. Brazilian Journal of Psychiatry. 42(6). 646–656. 25 indexed citations

Bird, Catherine, Tom Minichillo, & Curtis W. Marean. (2006). Edge damage distribution at the assemblage level on Middle Stone Age lithics: an image-based GIS approach. Journal of Archaeological Science. 34(5). 771–780. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact